Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU notified bodies numbers still yet to bottom out

This article was originally published in SRA

Executive Summary

EU notified body numbers are still sinking and the bottom is not yet in sight. This month Swissmedic announced that conformity assessment bodies (CABs) working in the EU medtech regulatory arena have been cut, by two, to three this year, in the wake a new ordinance (MedDO) that authorizes unannounced visits to manufacturers, among other new responsibilities1. Switzerland is indicative of the EU trend as it enacts EU medtech law and harmonizes with EU rules in order not to hinder its own trade.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT040562

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel